Merck Moves To Refuel Hypertensive Portfolio

The company gains exclusive rights to NicOx’ nitric oxide-donating technology for use with systemic hypertension treatments.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet